Biomedical effects of mushrooms with emphasis on pure compounds

Biomedical Journal

Volumn 37, Issue 6, 2014, Pages 357-368

  Paterson, R Russell M ^a   Lima, Nelson ^a  

^a UNIVERSITY OF MINHO   (Portugal)

Author keywords

cancer; Chinese; cordycepin; Ganoderma; polysaccharides

Indexed keywords

AGARICUS SUBRUFESCENS EXTRACT; AGARITINE; BETA GLUCAN; BLAZEIN; CLITOCINE; CORDYCEPIN; DIOLEOYLPHOSPHATIDYLETHANOLAMINE; ERGOSTEROL; ERINACINE DERIVATIVE; FUNGAL EXTRACT; GANODERMA LUCIDUM EXTRACT; GANOMYCIN B; GANOMYCIN I; GLUCAN; GRIFRON D; HERICENONE DERIVATIVE; IROFULVEN; KRESTIN; LENTINAN; LENTINULA EDODES EXTRACT; LUCIALDEHYDE DERIVATIVE; LUCIDENIC ACID; PLEUROTUS OSTREATUS EXTRACT; POLYSACCHARIDE; SCHIZOPHYLLAN; TRAMETES VERSICOLOR EXTRACT; TRITERPENE DERIVATIVE; TRITERPENOID; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; PLANT EXTRACT;

ADVANCED CANCER; AGARICUS SUBRUFESCENS; ANTIBACTERIAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIVIRAL ACTIVITY; ARTICLE; BLADDER CANCER; BREAST CANCER; CANCER SURVIVAL; CANCER THERAPY; CLINICAL COMPETENCE; CORDYCEPS; DIET SUPPLEMENTATION; DNA DAMAGE; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG EFFICACY; DRUG FATALITY; DRUG INDICATION; DRUG MANUFACTURE; DRUG PURIFICATION; DRUG PURITY; DRUG RESEARCH; DRUG SAFETY; DRUG STRUCTURE; DRUG TOLERABILITY; DRUG USE; ENDOMETRIUM CANCER; FOOD SAFETY; GANODERMA COLOSSUM; GANODERMA LUCIDUM; GLIOBLASTOMA; HUMAN; IC50; IMMUNOMODULATION; KIDNEY DISEASE; LEUKEMIA; LIVER CANCER; LIVER TOXICITY; LUNG CANCER; MALIGNANT NEOPLASTIC DISEASE; MEDICINAL MUSHROOM; MOLECULAR WEIGHT; MULTIPLE CYCLE TREATMENT; MUTAGENICITY; NEPHROTOXICITY; NEUTROPENIA; NONHUMAN; OMPHALOTUS OLEARIUS; OVARY CANCER; PANCREAS CANCER; PATENT; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PLEUROTUS OSTREATUS; PRESCRIPTION; PROSTATE CANCER; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SOLID TUMOR; STOMACH CANCER; TRAMETES VERSICOLOR; UNSPECIFIED SIDE EFFECT; UTERINE CERVIX CANCER; AGARICALES; ANIMAL; COMMUNICABLE DISEASES;

AGARICALES; ANIMALS; ANTI-BACTERIAL AGENTS; COMMUNICABLE DISEASES; HUMANS; MOLECULAR WEIGHT; PLANT EXTRACTS; PRESCRIPTIONS;

EID: 84920105794     PISSN: 23194170     EISSN: None     Source Type: Journal    
DOI: 10.4103/2319-4170.143502     Document Type: Article

References (103)

1. Wasser SP. Current findings, future trends, and unsolved problems in studies of medicinal mushrooms. Appl Microbiol Biotechnol 2011;89:1323-32.
2. Sullivan R, Smith JE, Rowan NJ. Medicinal mushrooms and cancer therapy: Translating a traditional practice into Western medicine. Perspect Biol Med 2006;49:159-70.
3. Saris WH, Asp NG, Björck I, Blaak E, Bornet F, Brouns F, et al. Functional food science and substrate metabolism. Br J Nutr 1998;80 Suppl 1:S47-75.
4. Sadler M, Saltmarsh M. Functional Foods: The Consumer, the Products and the Evidence. Cambridge: Royal Society of Chemistry; 1998.
5. Available From: http://www.theguardian.com/lifeandstyle/2014/mar/02/could-mushrooms-cure-cancer [Last accessed on 2014 Apr 01].
6. Paterson RR, Lima N. Toxicology of mycotoxins. EXS 2010;100:31-63.
7. Smith JE, Rowan NJ, Sullivan R. Medicinal Mushrooms: Their therapeutic properties and current medical usage with special emphasis on cancer treatments. May 2002; British Library. Available from: https://www.academia.edu/305933/Medicinal-Mushrooms-Their-therapeutic-properties-and-current-medical-usage-with-special-emphasis-on-cancer-treatments [Last accessed on 2014 Apr 02].
8. Available from: http://www.unitus.it/solidstatebioreactor/solidstatebioreactor.htm [Last accessed on 2014 Aug 28].
9. Paterson RR. Cordyceps-A traditional Chinese medicine and another fungal therapeutic biofactory? Phytochemistry 2008;69:1469-95.
10. Paterson RR. Ganoderma-a therapeutic fungal biofactory. Phytochemistry 2006;67:1985-2001.
11. nd ed. Seattle: Eastland Press; 1993.
12. Hobbs C. Medicinal Mushrooms: An Exploitation of Tradition, Healing and Culture. Santa Cruz: Botanica Press; 1995.
13. Capasso L. 5300 years ago, the ice man used natural laxatives and antibiotics. Lancet 1998;352:1864.
14. Peintner U, Pöder R, Pümpel T. The iceman's fungi. Mycol Res 1998;102:1153-62.
15. Mizuno T, Sakai T, Chihara G. Health foods and medicinal usage of mushrooms. Food Rev Int 1995;11:69-81.
16. Jong SC, Birmingham JM, Pai SH. Immunomodulatory substances of fungal origin. J Immunol Immunopharmacol 1991;11:115-22.
17. Ramberg JE, Nelson ED, Sinnott RA. Immunomodulatory dietary polysaccharides: A systematic review of the literature. Nutr J 2010;9:1-22.
18. Roupas P, Keogh J, Noakes M, Margetts C, Taylor P. The role of edible mushrooms in health: Evaluation of the evidence. J Funct Foods 2012;4:687-709.
19. Liao SF, Liang CH, Ho MY, Hsu TL, Tsai TI, Hsieh YS, et al. Immunization of fucose-containing polysaccharides from Reishi mushroom induces antibodies to tumor-associated Globo H-series epitopes. Proc Natl Acad Sci USA 2013;110:13809-14.
20. Lull C, Wichers HJ, Savelkoul HF. Antiinflammatory and immunomodulating properties of fungal metabolites. Mediators Inflamm 2005;2005:63-80.
21. Chan GC, Chan WK, Sze DM. The effects of beta-glucan on human immune and cancer cells. J Hematol Oncol 2009;2:25.
22. Boh B, Berovic M, Zhang J, Zhi-Bin L. Ganoderma lucidum and its pharmaceutically active compounds. Biotechnol Annu Rev 2007;13:265-301.
23. Cassileth BR. Complementary therapies: The American experience. Support Care Cancer 2000;8:16-23.
24. Hobbs C. Medicinal Mushrooms: An Exploration of Tradition, Healing and Culture. Summertown, Tenn: Botanica Press; 2003.
25. Jacobs DM, Gaudier E, van Duynhoven J, Vaughan EE. Non-digestible food ingredients, colonic microbiota and the impact on gut health and immunity: A role for metabolomics. Curr Drug Metab 2009;10:41-54.
26. Hanaue H, Tokuda Y, Machimura T, Kamijoh A, Kondo Y, Ogoshi K, et al. Effects of oral lentinan on T-cell subsets in peripheral venous blood. Clin Ther 1989;11:614-22.
27. Vetvicka V, Vashishta A, Saraswat-Ohri S, Vetvickova J. Immunological effects of yeast- and mushroom-derived beta-glucans. J Med Food 2008; 11:615-22.
28. Chan Y, Chang T, Chan CH, Yeh YC, Chen CW, Shieh B, et al. Immunomodulatory effects of Agaricus blazei Murill in Balb/cByJ mice. J Microbiol Immunol Infect 2007;40:201-8.
29. Takimoto H, Wakita D, Kawaguchi K, Kumazawa Y. Potentiation of cytotoxic activity in naive and tumor-bearing mice by oral administration of hot-water extracts from Agaricus blazei fruiting bodies. Biol Pharm Bull 2004;27:404-6.
30. Mizuno M, Morimoto M, Minato K, Tsuchida H. Polysaccharides from Agaricus blazei stimulate lymphocyte T-cell subsets in mice. Biosci Biotechnol Biochem 1998;62:434-7.
31. Yuminamochi E, Koike T, Takeda K, Horiuchi I, Okumura K. Interleukin-12-and interferon-gamma-mediated natural killer cell activation by Agaricus blazei Murill. Immunology 2007;121:197-206.
32. Lim BO, Yamada K, Cho BG, Jeon T, Hwang SG, Park T, et al. Comparative study on the modulation of IgE and cytokine production by Phellinus linteus grown on germinated brown rice, Phellinus linteus and germinated brown rice in murine splenocytes. Biosci Biotechnol Biochem 2004;68:2391-4.
33. Oh GS, Lee MS, Pae HO, Kwon J, Lee SS, Jeong JG, et al. Effects of oral administration of Phellinus linteus on the production of Th1- and Th2-type cytokines in mice. Immunopharmacol Immunotoxicol 2006;28:281-93.
34. Tsang KW, Lam CL, Yan C, Mak JC, Ooi GC, Ho JC, et al. Coriolus versicolor polysaccharide peptide slows progression of advanced non-small cell lung cancer. Respir Med 2003;97:618-24.
35. Available from; http://examine.com/supplements/Ganoderma+lucidum/. [Last accessed on 2014 Apr 01].
36. Lin JY, Chen ML, Lin BF. Ganoderma tsugae in vivo modulates Th1/Th2 and macrophage responses in an allergic murine model. Food Chem Toxicol 2006;44:2025-32.
37. Li H, Lu X, Zhang S, Lu M, Liu H. Anti-inflammatory activity of polysaccharide from Pholiota nameko. Biochemistry (Mosc) 2008;73:669-75.
38. Murakawa K, Fukunaga K, Tanouchi M, Hosokawa M, Hossain Z, Takahashi K. Therapy of myeloma in vivo using marine phospholipid in combination with Agaricus blazei Murill as an immune respond activator. J Oleo Sci 2007;56:179-88.
39. Kobayashi H, Yoshida R, Kanada Y, Fukuda Y, Yagyu T, Inagaki K, et al. Suppressing effects of daily oral supplementation of beta-glucan extracted from Agaricus blazei Murill on spontaneous and peritoneal disseminated metastasis in mouse model. J Cancer Res Clin Oncol 2005;131:527-38.
40. Zhang QH, Lin ZB. The antitumor activity of Ganoderma lucidum (Curt.: Fr.) P. Karst. (LingZhi) (Aphyllophoromycetidease) polysaccharides is related to tumor necrosis factor-alpha and interferon-gamma. Int J Med Mushrooms 1999;1:207-15.
41. Lu H, Kyo E, Uesaka T, Katoh O, Watanabe H. Prevention of development of N, N'-dimethylhydrazine-induced colon tumors by a water-soluble extract from cultured medium of Ganoderma lucidum (Rei-shi) mycelia in male ICR mice. Int J Mol Med 2002;9:113-7.
42. Lu H, Kyo E, Uesaka T, Katoh O, Watanabe H. A water-soluble extract from cultured medium of Ganoderma lucidum (Rei-shi) mycelia suppresses azoxymethane-induction of colon cancers in male F344 rats. Oncol Rep 2003;10:375-9.
43. Kurashige S, Akuzawa Y, Endo F. Effects of Lentinus edodes, Grifola frondosa and Pleurotus ostreatus administration on cancer outbreak, and activities of macrophages and lymphocytes in mice treated with a carcinogen, N-butyl-N-butanolnitrosoamine. Immunopharmacol Immunotoxicol 1997;19:175-83.
44. Hishida I, Nanba H, Kuroda H. Antitumor activity exhibited by orally administered extract from fruit body of Grifola frondosa (Maitake). Chem Pharm Bull (Tokyo) 1988;36:1819-27.
45. Nanba H, Kubo K. Effect of Maitake D-fraction on cancer prevention. Ann N Y Acad Sci 1997;833:204-7.
46. Nanba H, Mori K, Toyomasu T, Kuroda H. Antitumor action of shiitake (Lentinus edodes) fruit bodies orally administered to mice. Chem Pharm Bull (Tokyo) 1987;35:2453-8.
47. Sugui MM, Alves de Lima PL, Delmanto RD, da Eira AF, Salvadori DM, Ribeiro LR. Antimutagenic effect of Lentinula edodes (BERK.) Pegler mushroom and possible variation among lineages. Food Chem Toxicol 2003;41:555-60.
48. de Vere White RW, Hackman RM, Soares SE, Beckett LA, Sun B. Effects of a mushroom mycelium extract on the treatment of prostate cancer. Urology 2002;60:640-4.
49. Yap AT, Ng ML. Immunopote ntiating properties of lentinan (1-3)-b-Dglucan extracted from culinary-medicinal Shiitake mushroom. Int J Med Mushrooms 2003;5:19-39.
50. Ng ML, Yap AT. Inhibition of human colon carcinoma development by lentinan from shiitake mushrooms (Lentinus edodes). J Altern Complement Med 2002;8:581-9.
51. Fujii T, Maeda H, Suzuki F, Ishida N. Isolation and characterization of a new antitumor polysaccharide, KS-2, extracted from culture mycelia of Lentinus edodes. J Antibiot (Tokyo) 1978;31:1079-90.
52. Gan L, Hua Zhang S, Liang Yang X, Bi Xu H. Immunomodulation and antitumor activity by a polysaccharide-protein complex from Lycium barbarum. Int Immunopharmacol 2004;4:563-9.
53. Jin M, Jeon H, Jung HJ, Kim B, Shin SS, Choi JJ, et al. Enhancement of repopulation and hematopoiesis of bone marrow cells in irradiated mice by oral administration of PG101, a water-soluble extract from Lentinus lepideus. Exp Biol Med (Maywood) 2003;228:759-66.
54. Ito H, Shimura K, Itoh H, Kawade M. Antitumor effects of a new polysaccharide-protein complex (ATOM) prepared from Agaricus blazei (Iwade strain 101) 'Himematsutake' and its mechanisms in tumor-bearing mice. Anticancer Res 1997;17:277-84.
55. Ho JC, Konerding MA, Gaumann A, Groth M, Liu WK. Fungal polysaccharopeptide inhibits tumor angiogenesis and tumor growth in mice. Life Sci 2004;75:1343-56.
56. Tao YZ, Zhang L, Cheung PC. Physicochemical properties and antitumor activities of water-soluble native and sulfated hyperbranched mushroom polysaccharides. Carbohydr Res 2006;341:2261-9.
57. Lin SB, Li CH, Lee SS, Kan LS. Triterpene-enriched extracts from Ganoderma lucidum inhibit growth of hepatoma cells via suppressing protein kinase C, activating mitogen-activated protein kinases and G2-phase cell cycle arrest. Life Sci 2003;72:2381-90.
58. Mitomi T, Tsuchiya S, Iijima N, Aso K, Suzuki K, Nishiyama K, et al. Randomized, controlled study on adjuvant immunochemotherapy with PSK in curatively resected colorectal cancer. The Cooperative Study Group of Surgical Adjuvant Immunochemotherapy for Cancer of Colon and Rectum (Kanagawa). Dis Colon Rectum. 1992;35:123-30.
59. Ito K, Nakazato H, Koike A, Takagi H, Saji S, Baba S, et al. Long-term effect of 5-fluorouracil enhanced by intermittent administration of polysaccharide K after curative resection of colon cancer. A randomized controlled trial for 7-year follow-up. Int J Colorectal Dis 2004;19:157-64.
60. Ohwada S, Ikeya T, Yokomori T, Kusaba T, Roppongi T, Takahashi T, et al. Adjuvant immunochemotherapy with oral Tegafur/Uracil plus PSK in patients with stage II or III colorectal cancer: A randomised controlled study. Br J Cancer 2004;90:1003-10.
61. Nakazato H, Koike A, Saji S, Ogawa N, Sakamoto J. Efficacy of immunochemotherapy as adjuvant treatment after curative resection of gastric cancer. Study Group of Immunochemotherapy with PSK for Gastric Cancer. Lancet 1994;343:1122-6.
62. Tsujitani S, Kakeji Y, Orita H, Watanabe A, Kohnoe S, Baba H, et al. Postoperative adjuvant immunochemotherapy and infiltration of dendritic cells for patients with advanced gastric cancer. Anticancer Res 1992;12:645-8.
63. Torisu M, Hayashi Y, Ishimitsu T, Fujimura T, Iwasaki K, Katano M, et al. Significant prolongation of disease-free period gained by oral polysaccharide K (PSK) administration after curative surgical operation of colorectal cancer. Cancer Immunol Immunother 1990;31:261-8.
64. Nio Y, Tsubono M, Tseng CC, Morimoto H, Kawabata K, Masai Y, et al. Immunomodulation by orally administered protein-bound polysaccharide PSK in patients with gastrointestinal cancer. Biotherapy 1992;4:117-28.
65. Ahn WS, Kim DJ, Chae GT, Lee JM, Bae SM, Sin JI, et al. Natural killer cell activity and quality of life were improved by consumption of a mushroom extract, Agaricus blazei Murill Kyowa, in gynecological cancer patients undergoing chemotherapy. Int J Gynecol Cancer 2004;14:589-94.
66. Mukai H, Watanabe T, Ando M, Katsumata N. An alternative medicine, Agaricus blazei, may have induced severe hepatic dysfunction in cancer patients. Jpn J Clin Oncol 2006;36:808-10.
67. Yuen MF, Ip P, Ng WK, Lai CL. Hepatotoxicity due to a formulation of Ganoderma lucidum (Lingzhi). J Hepatol 2004;41:686-7.
68. Levy AM, Kita H, Phillips SF, Schkade PA, Dyer PD, Gleich GJ, et al. Eosinophilia and gastrointestinal symptoms after ingestion of Shiitake mushrooms. J Allergy Clin Immunol 1998;101:613-20.
69. Al-Deen IH, Twaij HA, Al-Badr AA, Istarabadi TA. Toxicologic and histopathologic studies of Pleurotus ostreatus mushroom in mice. J Ethnopharmacol 1987;21:297-305.
70. Wong YY, Moon A, Duffin R, Barthet-Barateig A, Meijer HA, Clemens MJ, et al. Cordycepin inhibits protein synthesis and cell adhesion through effects on signal transduction. J Biol Chem 2010;285:2610-21.
71. Lee SJ, Kim SK, Choi WS, Kim WJ, Moon SK. Cordycepin causes p21WAF1-mediated G2/M cell-cycle arrest by regulating c-jun N-terminal kinase activation in human bladder cancer cells. Arch Biochem Biophys 2009;490:103-9.
72. Wei HP, Ye XL, Chen Z, Zhong YJ, Li PM, Pu SC, et al. Synthesis and pharmacokinetic evaluation of novel N-acyl-cordycepin derivatives with a normal alkyl chain. Eur J Med Chem 2009;44:665-9.
73. Paterson RR, Sariah M, Lima N, Zainal Abidin MA, Santos C. Mutagenic and inhibitory compounds produced by fungi affect detrimentally diagnosis and phylogenetic analyses. Curr Bioact Compd 2008;4:245-57.
74. Paterson RR. Fungal enzyme inhibitors as pharmaceuticals, toxins and scourge of PCR. Curr Enzym Inhib 2008;4:46-59.
75. Zhang M, Huang J, Xie X, Holman CD. Dietary intakes of mushrooms and green tea combine to reduce the risk of breast cancer in Chinese women. Int J Cancer 2009;124:1404-8.
76. Jiang J, Slivova V, Harvey K, Valachovicova T, Sliva D. Ganoderma lucidum suppresses growth of breast cancer cells through the inhibition of Akt/NF-κB signaling. Nutr Cancer 2004;49:209-16.
77. Jiang J, Slivova V, Sliva D. Ganoderma lucidum inhibits proliferation of human breast cancer cells by down-regulation of estrogen receptor and NF-κB signaling. Int J Oncol 2006;29:695-703.
78. Jin CY, Kim GY, Choi YH. Induction of apoptosis by aqueous extract of Cordyceps militaris through activation of caspases and inactivation of akt in human breast cancer MDA-MB-231 cells. J Microbiol Biotechnol 2008;18:1997-2003.
79. Jiang J, Grieb B, Thyagarajan A, Sliva D. Ganoderic acids suppress growth and invasive behavior of breast cancer cells by modulating AP-1 and NF-κB signaling. Int J Mol Med 2008;21:577-84.
80. Endo M, Beppu H, Akiyama H, Wakamatsu K, Ito S, Kawamoto Y, et al. Agaritine purified from Agaricus blazei murrill exerts anti-tumor activity against leukemic cells. Biochim Biophys Acta 2010;1800:669-73.
81. Akiyama H, Endo M, Matsui T, Katsuda I, Emi N, Kawamoto Y, et al. Agaritine from Agaricus blazei murrill induces apoptosis in the leukemic cell line U937. Biochim Biophys Acta 2011;1810:519-25.
82. Roupas P, Keogh J, Noakes M, Margetts C, Taylor P. Mushrooms and agaritine: A mini-review. J Funct Foods 2010;2:91-8.
83. Ren G, Zhao YP, Yang L, Fu CX. Anti-proliferative effect of clitocine from the mushroom Leucopaxillus giganteus on human cervical cancer HeLa cells by inducing apoptosis. Cancer Lett 2008;262:190-200.
84. Weng CJ, Chau CF, Chen KD, Chen DH, Yen GC. The anti-invasive effect of lucidenic acids isolated from a new Ganoderma lucidum strain. Mol Nutr Food Res 2007;51:1472-7.
85. Wu JY, Zhang QX, Leung PH. Inhibitory effects of ethyl acetate extract of Cordyceps sinensis mycelium on various cancer cells in culture and B16 melanoma in C57BL/6 mice. Phytomed 2007;14:43-9.
86. Youn MJ, Kim JK, Park SY, Kim Y, Kim SJ, Lee JS, et al. Chaga mushroom (Inonotus obliquus) induces G0/G1 arrest and apoptosis in human hepatoma HepG2 cells. World J Gastroenterol 2008;14:511-7.
87. Assimos DG. Re: Chaga mushroom-induced oxalate nephropathy: Editorial comment. J Urol 2013;189:1768-9.
88. Available from: http://www.newsrx.com/newsletters/Clinical-Trials-Week.html; http://business.highbeam.com/articles/436989/r-d-focus-drug-news. [Last accessed on 2014 Apr 01].
89. Gao JJ, Min BS, Ahn EM, Nakamura N, Lee HK, Hattori M. New triterpene aldeydes, lucialdehydes A-C, from Ganoderma lucidum and their cytotoxicity against murine and human tumor cells. Chem Pharm Bull (Tokyo) 2002;50:837-40.
90. Itoh H, Ito H, Hibasami H. Blazein of a new steroid isolated from Agaricus blazei Murrill (Himematsutake) induces cell death and morphological change indicative of apoptotic chromatin condensation in human lung cancer LU99 and stomach cancer KATO III cells. Oncol Rep 2008;20:1359-61.
91. Eckhardt SG, Baker SD, Britten CD, Hidalgo M, Siu L, Hammond LA, et al. Phase I and pharmacokinetic study of irofulven, a novel mushroom-derived cytotoxin, administered for five consecutive days every four weeks in patients with advanced solid malignancies. J Clin Oncol 2000;18:4086-97.
92. Available from: http://www.newsrx.com/newsletters/Clinical-Trials-Week.html; http://business.highbeam.com/articles/436989/r-d-focus-drug-news [Last accessed on 2014 Apr 01].
93. El Dine RS, El Halawany AM, Ma CM, Hattori M. Inhibition of the dimerization and active site of HIV-1 protease by secondary metabolites from the Vietnamese mushroom Ganoderma colossum. J Nat Prod 2009;72:2019-23.
94. Kondo K, Watanabe A, Akiyama H, Maitani T. The metabolisms of agaritine, a mushroom hydrazine in mice. Food Chem Toxicol 2008;46:854-62.
95. Paterson RR, Lima N. Mutagens manufactured in fungal culture may affect DNA/RNA of producing fungi. J Appl Microbiol 2009;106:1070-80.
96. Paterson RR, Lima N. Biochemical mutagens affect the preservation of fungi and biodiversity estimations. Appl Microbiol Biotechnol 2013;97:77-85.
97. Paterson RR, Lima N. Self mutagens affect detrimentally PCR analysis of food fungi by creating potential mutants. Food Control 2014;35:329-37.
98. Bernardshaw S, Hetland G, Grinde B, Johnson E. An extract of the mushroom Agaricus blazei Murill protects against lethal septicemia in a mouse model of fecal peritonitis. Shock 2006;25:420-5.
99. Suzuki I, Hashimoto K, Ohno N, Tanaka H, Yadomae T. Immunomodulation by orally administered beta-glucan in mice. Int J Immunopharmacol 1989;11:761-9.
100. Suzuki I, Sakurai T, Hashimoto K. Inhibition of experimental pulmonary metastasis of Lewis lung carcinoma by orally administered beta-glucan in mice. Chem Pharm Bull (Tokyo) 1991;39:1606-8.
101. Rice PJ, Adams EL, Ozment-Skelton T, Gonzalez AJ, Goldman MP, Lockhard BE, et al. Oral delivery and gastrointestinal absorption of soluble glucans stimulate increased resistance to infectious challenge. J Pharmacol Exp Ther 2005;314:1079-86.
102. Furlanetto TW. Vitamin D2 could be one of the protective phytochemicals. Int J Cancer 2009;125:1994.
103. Kawagishi H, Zhuang C. Compounds for dementia from Hericium erinaceum. Drugs Future 2008;33:149-55.